News

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...
A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the ...
Vinay Prasad is taking on several big roles at the FDA, solidifying his position as a top adviser to Commissioner Marty ...
The agency declined to quickly release documents that would identify drugs made at some of the most troubled foreign ...